PharmD Info

As new CIOMS reports are published, more terms and definitions will be added. At the time of writing, four new CIOMS pharmacovigilance reports are being prepared:

• Patient Involvement in the Development and Safe Use of Medicines (CIOMS XI);

• Benefit-Risk Balance for Medicinal Products (CIOMS XII) - this will be an update of CIOMS IV on Benefit-Risk Balance for Marketed Drugs: Evaluation of Safety Signals, originally published in 1998;

• Real-World Data and Real-World Evidence in Regulatory Decision Making (CIOMS XIII);

• Severe Cutaneous Adverse Reactions of Drugs (SCARs).

Download - CIOMS Cumulative Pharmacovigilance Glossary: Version 1.1